Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 4
1984 1
1985 4
1986 4
1988 2
1989 8
1990 1
1991 3
1992 9
1993 3
1994 3
1995 2
1996 1
1997 2
2004 1
2005 1
2007 1
2009 3
2010 4
2011 2
2014 2
2015 3
2016 1
2017 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: 79335-75-4
Page 1
Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice.
Mine Y, Yokota Y, Wakai Y, Fukada S, Nishida M, Goto S, Kuwahara S. Mine Y, et al. J Antibiot (Tokyo). 1983 Aug;36(8):1045-50. doi: 10.7164/antibiotics.36.1045. J Antibiot (Tokyo). 1983. PMID: 6415029 Free article.
The protective effect of an immunoactive peptide, D-lactoyl-L-alanyl-gamma-D-glutamyl-(L)-meso-diaminopimelyl-(L)-glycine (FK-156) and a related compound, heptanoyl-gamma-D-glutamyl-(L)-meso-diaminopimelyl-(D)-alanine …
The protective effect of an immunoactive peptide, D-lactoyl-L-alanyl-gamma-D-glutamyl-(L)-meso-diaminopimelyl-(L)-glycine (FK-156) and a rel …
Immunoactive peptides, FK-156 and FK-565. II. Restoration of host resistance to microbial infection in immunosuppressed mice.
Yokota Y, Mine Y, Wakai Y, Watanabe Y, Nishida M, Goto S, Kuwahara S. Yokota Y, et al. J Antibiot (Tokyo). 1983 Aug;36(8):1051-8. doi: 10.7164/antibiotics.36.1051. J Antibiot (Tokyo). 1983. PMID: 6415030 Free article.
The immunoactive peptides, FK-156 and its analogue, FK-565 were evaluated in various models of mice immunosuppressed with cyclophosphamide, hydrocortisone, mitomycin C, carrageenan and tumor cells. Treatment with FK-156 (subcutaneous) and FK-565 (oral) …
The immunoactive peptides, FK-156 and its analogue, FK-565 were evaluated in various models of mice immunosuppressed with cycl …
Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.
Weissmann N, Leyhausen G, Maidhof A, Tanaka W, Umezawa H, Müller WE. Weissmann N, et al. J Antibiot (Tokyo). 1985 Jun;38(6):772-8. doi: 10.7164/antibiotics.38.772. J Antibiot (Tokyo). 1985. PMID: 4019321 Free article.
No effects on these enzymes were caused by amastatin (an AP-A inhibitor), FK-156, FK-565 and Bu-2743E; the latter peptide turned out to be not an inhibitor of cell surface associated microsomal Leu-AP but an inhibitor of cytosolic Leu-AP. ...These mitogenic actions …
No effects on these enzymes were caused by amastatin (an AP-A inhibitor), FK-156, FK-565 and Bu-2743E; the latter peptide turn …
Immunoactive peptides, FK-156 and FK-565. III. Enhancement of host defense mechanisms against infection.
Mine Y, Watanabe Y, Tawara S, Yokota Y, Nishida M, Goto S, Kuwahara S. Mine Y, et al. J Antibiot (Tokyo). 1983 Aug;36(8):1059-66. doi: 10.7164/antibiotics.36.1059. J Antibiot (Tokyo). 1983. PMID: 6630057 Free article.
We investigated the effect of immunoactive peptides, FK-156 and FK-565 on host defense mechanisms against microbial invasion. It was shown that these drugs given to normal mice increased the counts of phagocytes in both peripheral blood and peritoneal cavity, and en …
We investigated the effect of immunoactive peptides, FK-156 and FK-565 on host defense mechanisms against microbial invasion. …
Immunoactive peptides, FK 156 and FK 565. IV. Activation of mouse macrophages.
Watanabe Y, Tawara S, Mine Y, Kikuchi H. Watanabe Y, et al. J Antibiot (Tokyo). 1985 Dec;38(12):1781-7. doi: 10.7164/antibiotics.38.1781. J Antibiot (Tokyo). 1985. PMID: 3005214 Free article.
We investigated the effects of the immunoactive peptides, FK 156 and FK 565, on functions of mouse macrophages. FK 156 and FK 565 given parenterally or orally to mice enhanced spreading of peritoneal macrophages, phagocytosis of latex particles and int …
We investigated the effects of the immunoactive peptides, FK 156 and FK 565, on functions of mouse macrophages. FK 156 and …
Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitro.
Ahmed K, Turk JL. Ahmed K, et al. Cancer Immunol Immunother. 1989;28(2):87-92. doi: 10.1007/BF00199107. Cancer Immunol Immunother. 1989. PMID: 2783891 Free PMC article.
Four anticancer agents, neothramycin, aclacinomycin, FK-565 and FK-156, were tested for their effects on concanavalin-A-induced interleukin-2 release from rat splenocytes in vitro. ...Neothramycin and aclacinomycin did not affect the release of interleukin-1; howeve …
Four anticancer agents, neothramycin, aclacinomycin, FK-565 and FK-156, were tested for their effects on concanavalin-A-induce …
Pharmacotherapy of dilated cardiomyopathy: current status and future directions.
Kawai C. Kawai C. Cardiovasc Drugs Ther. 1992 Feb;6(1):7-10. doi: 10.1007/BF00050909. Cardiovasc Drugs Ther. 1992. PMID: 1349497 Review.
However, immunosuppressive treatment in acute myocarditis should be reevaluated with the use of newly developed antiviral agents. A new synthetic immunoactive peptide FK 565, given before or simultaneously with viral inoculation, proved effective in inhibiting myoca …
However, immunosuppressive treatment in acute myocarditis should be reevaluated with the use of newly developed antiviral agents. A new synt …
Role of human blood monocytes in up-regulation of lymphokine (interleukin-2)-activated killer cell activity with cisplatin and FK-565.
Sodhi A, Basu S. Sodhi A, et al. Nat Immun. 1992 Mar-Apr;11(2):105-16. Nat Immun. 1992. PMID: 1498519
Treatment of peripheral-blood mononuclear cells (PBMC) with CP or FK-565 in the presence of IL-2 resulted in a significant increase in LAK activity against NK-resistant Raji cells, as assessed by the 4-hour 51Cr release assay, depending on the dose of CP, FK- …
Treatment of peripheral-blood mononuclear cells (PBMC) with CP or FK-565 in the presence of IL-2 resulted in a significant inc …
New convenient synthesis of immunostimulating peptides containing meso-diaminopimelic acid. Syntheses of FK-565 and FK-156.
Kolodziejczyk AM, Kolodziejczyk AS, Stoev S. Kolodziejczyk AM, et al. Int J Pept Protein Res. 1992 Apr;39(4):382-7. doi: 10.1111/j.1399-3011.1992.tb01598.x. Int J Pept Protein Res. 1992. PMID: 1428528
A new improved synthesis of two immunostimulating peptides: FK-156 (D-lactyl-alanyl-gamma-D-glutamyl-(L)-meso-2,6-diaminopimelyl-(L)- glycine) and FK-565 (heptanoyl-gamma-D-glutamyl-(L)-meso-2,6-diaminopimelyl-(L)- D-alanine) is described. ...
A new improved synthesis of two immunostimulating peptides: FK-156 (D-lactyl-alanyl-gamma-D-glutamyl-(L)-meso-2,6-diaminopimelyl-(L)- glycin …
Nod1 ligands induce site-specific vascular inflammation.
Nishio H, Kanno S, Onoyama S, Ikeda K, Tanaka T, Kusuhara K, Fujimoto Y, Fukase K, Sueishi K, Hara T. Nishio H, et al. Arterioscler Thromb Vasc Biol. 2011 May;31(5):1093-9. doi: 10.1161/ATVBAHA.110.216325. Epub 2011 Feb 17. Arterioscler Thromb Vasc Biol. 2011. PMID: 21330608 Free article.
62 results